Company / Operating Income per Share
RECURSION PHARMACEUTICALS, INC. Operating Income per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.63
FY2025
5-year range
-$8.19 / -$0.50
FY2021-FY2025
Trend
+20.1%
vs FY2024
Sector context
#105 of 201
Health Care
What the data says
At $-1.63, RECURSION PHARMACEUTICALS, INC.'s operating income per share ranks #105 of 201 in the Health Care sector. Operating Income per Share returned to growth in FY2025 after 2 years of decline, reaching $-1.63.
Based on SEC 10-K filings.
-1.63 in FY2025.
Improved from $-1.83 to $-1.63 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#105 of 201 in Health CareTop 52% of 201This company -$1.63 Sector average -$3.23
▼
+49.5% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 20.1% year-over-year.
- Ranks #105 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2022.
- Lowest operating income per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.80 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.63 | +20.1% |
| FY2024 | -$2.04 | -11.6% |
| FY2023 | -$1.83 | -268.8% |
| FY2022 | -$0.50 | +93.9% |
| FY2021 | -$8.19 | -110.8% |
| FY2020 | -$3.88 | -34.2% |
| FY2019 | -$2.89 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026